Pakistan gets 2.5 million doses of Moderna Covid-19 vaccine from US

Pakistan received 2.5 million doses of the Moderna vaccine from the United States on Friday, easing pressure on Islamabad in overcoming the shortage of COVID-19 vaccines.

Topics
Coronavirus Vaccine | Pakistan  | United States

AP  |  Islamabad 

Moderna vaccine
Photo: Shutterstock

received 2.5 million doses of the Moderna vaccine from the on Friday, easing pressure on Islamabad in overcoming the shortage of COVID-19 vaccines.

According to a US embassy statement, the vaccines were delivered to the Pakistani people in partnership with the COVAX global vaccine initiative, UNICEF, and the government of

It says this donation was part of the 80 million doses the was sharing with the world, delivering on our pledge to facilitate equitable global access to safe and effective vaccines, which are essential to ending the COVID-19 pandemic.

The latest development comes days after hundreds of Pakistani expatriate workers rallied in Islamabad, demanding they should be quickly vaccinated with the Moderna, Pfizer or AstraZeneca vaccines so they can travel abroad.

has mostly relied on Chinese vaccines, but some Middle Eastern countries want travelers to produce a certificate to show they've received specific vaccines.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Vaccine
First Published: Sat, July 03 2021. 08:42 IST
RECOMMENDED FOR YOU